Acquired Hypothalamic Obesity

Monterey, California, August 10, 2026 Elevation Spine announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...

San Francisco, California, August 12, 2026 Tasman Therapeutics announced a multi-year strategic partnership with Osmind to support the development...

Boston, Massachusetts, August 11, 2026 Rhythm Pharmaceuticals announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA)...

BOSTON, August 4, 2026 Rhythm Pharmaceuticals announced encouraging preliminary Phase 2 clinical trial results for RM-718, its investigational once-weekly...

BOSTON, Mass., July 8, 2026 Rhythm Pharmaceuticals announced that the New England Journal of Medicine (NEJM) has published the...